Masters Capital Management Has Lifted Teradyne (Call) (TER) Position; Hillsdale Investment Management Has Lowered Quest Diagnostics (DGX) Stake By $323,000

January 18, 2018 - By Neil V. Hobbs

Hillsdale Investment Management Inc decreased Quest Diagnostics Inc (DGX) stake by 85% reported in 2017Q3 SEC filing. Hillsdale Investment Management Inc sold 3,400 shares as Quest Diagnostics Inc (DGX)’s stock rose 10.72%. The Hillsdale Investment Management Inc holds 600 shares with $57,000 value, down from 4,000 last quarter. Quest Diagnostics Inc now has $13.84B valuation. The stock increased 0.08% or $0.08 during the last trading session, reaching $101.57. About 487,658 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has risen 39.04% since January 18, 2017 and is uptrending. It has outperformed by 22.34% the S&P500.

Masters Capital Management Llc increased Teradyne Inc (Call) (TER) stake by 13.19% reported in 2017Q3 SEC filing. Masters Capital Management Llc acquired 139,800 shares as Teradyne Inc (Call) (TER)’s stock rose 19.47%. The Masters Capital Management Llc holds 1.20M shares with $44.75 million value, up from 1.06 million last quarter. Teradyne Inc (Call) now has $9.26B valuation. The stock increased 0.95% or $0.45 during the last trading session, reaching $47.21. About 2.50 million shares traded or 6.72% up from the average. Teradyne, Inc. (NYSE:TER) has risen 88.99% since January 18, 2017 and is uptrending. It has outperformed by 72.29% the S&P500.

Masters Capital Management Llc decreased Metlife Inc (NYSE:MET) stake by 2.81 million shares to 1.00M valued at $51.95M in 2017Q3. It also reduced Metlife Inc (Call) (NYSE:MET) stake by 2.00M shares and now owns 1.81 million shares. United Parcel Service Inc (Call) (NYSE:UPS) was reduced too.

Since August 1, 2017, it had 0 buys, and 7 sales for $5.32 million activity. On Thursday, August 31 the insider BRADLEY MICHAEL A sold $790,067. 12,045 Teradyne, Inc. (NYSE:TER) shares with value of $508,179 were sold by Robbins Brad. GILLIS EDWIN J had sold 41,000 shares worth $1.46M. JAGIELA MARK E sold $1.04M worth of stock or 30,000 shares. Gray Charles Jeffrey sold $344,763 worth of Teradyne, Inc. (NYSE:TER) on Friday, October 27.

Investors sentiment decreased to 0.96 in 2017 Q3. Its down 0.25, from 1.21 in 2017Q2. It dropped, as 37 investors sold TER shares while 130 reduced holdings. 61 funds opened positions while 100 raised stakes. 185.56 million shares or 2.84% more from 180.44 million shares in 2017Q2 were reported. 56,712 are owned by Profund Advsr Limited Liability Co. Legal And General Grp Public Limited Com holds 0.01% or 230,081 shares in its portfolio. Stephens Ar holds 0.01% of its portfolio in Teradyne, Inc. (NYSE:TER) for 9,919 shares. Louisiana State Employees Retirement System has 0.09% invested in Teradyne, Inc. (NYSE:TER). Bancorporation Of Montreal Can reported 568,026 shares or 0.02% of all its holdings. Citadel Advsrs Lc owns 0.02% invested in Teradyne, Inc. (NYSE:TER) for 538,800 shares. Van Eck Assoc accumulated 340,488 shares. Paradigm Cap Mgmt Inc holds 126,150 shares. Advisory Net invested 0.09% in Teradyne, Inc. (NYSE:TER). Yhb Advsr Incorporated holds 0.04% or 5,720 shares in its portfolio. Sumitomo Life Insur Co holds 58,283 shares. Rhumbline Advisers has 421,059 shares. Axa stated it has 1.44M shares. 5.36M are owned by State Street. Sei Invs stated it has 403,453 shares or 0.05% of all its holdings.

Among 16 analysts covering Teradyne (NYSE:TER), 9 have Buy rating, 0 Sell and 7 Hold. Therefore 56% are positive. Teradyne had 40 analyst reports since August 25, 2015 according to SRatingsIntel. On Friday, July 28 the stock rating was upgraded by KeyBanc Capital Markets to “Overweight”. The firm has “Hold” rating by Craig Hallum given on Friday, July 29. Sidoti maintained Teradyne, Inc. (NYSE:TER) on Wednesday, September 23 with “Buy” rating. The stock has “Outperform” rating by Cowen & Co on Tuesday, December 6. As per Wednesday, February 3, the company rating was downgraded by Goldman Sachs. The stock of Teradyne, Inc. (NYSE:TER) earned “Buy” rating by Needham on Thursday, October 26. The stock of Teradyne, Inc. (NYSE:TER) earned “Buy” rating by KeyBanc Capital Markets on Thursday, October 12. Cowen & Co maintained it with “Outperform” rating and $34 target in Thursday, January 26 report. As per Monday, November 20, the company rating was downgraded by Deutsche Bank. Needham maintained it with “Buy” rating and $40 target in Friday, April 28 report.

Since August 4, 2017, it had 0 buys, and 6 sales for $17.85 million activity. The insider LEIDEN JEFFREY M sold $31,571. Another trade for 2,525 shares valued at $272,768 was made by RUSCKOWSKI STEPHEN H on Tuesday, September 5. $6.30M worth of Quest Diagnostics Incorporated (NYSE:DGX) shares were sold by Davis J. E.. 3,803 shares valued at $410,762 were sold by STANZIONE DANIEL on Tuesday, September 5.

Hillsdale Investment Management Inc increased Firstservice Corp New stake by 6,000 shares to 194,650 valued at $12.80 million in 2017Q3. It also upped Dynex Cap Inc (NYSE:DX) stake by 125,500 shares and now owns 266,500 shares. Enbridge Inc (NYSE:ENB) was raised too.

Among 21 analysts covering Quest Diagnostics (NYSE:DGX), 7 have Buy rating, 2 Sell and 12 Hold. Therefore 33% are positive. Quest Diagnostics had 58 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Buy” rating given on Sunday, June 11 by Canaccord Genuity. As per Tuesday, July 25, the company rating was maintained by Canaccord Genuity. Canaccord Genuity maintained the shares of DGX in report on Wednesday, November 22 with “Buy” rating. The rating was initiated by Citigroup with “Neutral” on Friday, September 9. Mizuho maintained Quest Diagnostics Incorporated (NYSE:DGX) rating on Thursday, October 22. Mizuho has “Neutral” rating and $68 target. The firm earned “Neutral” rating on Friday, October 20 by Citigroup. Bank of America upgraded the shares of DGX in report on Tuesday, July 25 to “Buy” rating. The firm has “Buy” rating by Mizuho given on Thursday, October 19. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Buy” rating given on Tuesday, January 16 by Canaccord Genuity. Goldman Sachs upgraded the shares of DGX in report on Monday, December 12 to “Buy” rating.

Investors sentiment decreased to 0.98 in Q3 2017. Its down 0.01, from 0.99 in 2017Q2. It dropped, as 51 investors sold DGX shares while 184 reduced holdings. 57 funds opened positions while 173 raised stakes. 116.90 million shares or 2.64% more from 113.89 million shares in 2017Q2 were reported. Cls Invs Lc owns 35 shares. 58,872 were accumulated by Oppenheimer And Communication. Moreover, Cape Cod Five Cents Savings Bank has 0.05% invested in Quest Diagnostics Incorporated (NYSE:DGX). Willis Counsel owns 27,200 shares or 0.18% of their US portfolio. Washington Trust National Bank & Trust invested 0.01% in Quest Diagnostics Incorporated (NYSE:DGX). Caisse De Depot Et Placement Du Quebec has invested 0.01% in Quest Diagnostics Incorporated (NYSE:DGX). Citadel Limited Com reported 317,199 shares. 174,687 are held by Voya Management Lc. Schnieders Capital Management Lc has invested 0.1% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Colony Gp holds 13,419 shares or 0.09% of its portfolio. 1,876 are owned by Rampart Investment Mgmt Company Ltd Liability Corporation. Veritas Investment Limited Liability Partnership has 1,300 shares for 0.02% of their portfolio. Janney Montgomery Scott Limited holds 0.01% in Quest Diagnostics Incorporated (NYSE:DGX) or 7,649 shares. Bokf Na reported 12,995 shares. Td Asset Management holds 45,124 shares or 0.01% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: